Establishment of New Ovarian and Colon Carcinoma Cell Lines: Differentiation is Only Possible by Cytokeratin Analysis

Overview

Journal Br J Cancer

Specialty Oncology

Date 1994 Mar 1

PMID 7510115

Citations 3

Authors

V J Mobus

R Moll

C D Gerharz

D G Kieback

W Weikel

G Hoffmann

R Kreienberg

Affiliations

Soon will be listed here.

Abstract

Two human ovarian (OV-MZ-10, OV-MZ-15) and two colon cancer cell lines (CO-MZ-5, CO-MZ-6) were newly established in permanent cell culture. These cell lines have been maintained in vitro for 5-6 years, the passage number varying from 25 to 228. They were established from ascites or solid tumours at the time of primary surgery. By clinical and histopathological judgement alone all four cell lines would have been interpreted as ovarian cancer cell lines. Morphological criteria or the expression of the tumour-associated antigens CA-125 and CEA allowed no differential diagnosis. Only the analysis of the expression of different cytokeratins and vimentin enabled us to verify the different origin of the cell lines. Ovarian cancer cell lines, in contrast to the colon cancer cell lines, are positive for the expression of cytokeratin (CK) 7 and for vimentin. CK 20 proved to be the marker with the best discrimination. CK 20 was found exclusively in the colon carcinoma cell lines, but not in the ovarian carcinoma cell lines. The evaluation of cytokeratin expression is a helpful diagnostic modality in differentiating between adenocarcinoma cell lines derived from ovarian and colon tumours.

Citing Articles

Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.

Knor S, Sato S, Huber T, Morgenstern A, Bruchertseifer F, Schmitt M Eur J Nucl Med Mol Imaging. 2007; 35(1):53-64.

PMID: 17891393 DOI: 10.1007/s00259-007-0582-3.

Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20.

Yanagibashi T, Gorai I, Nakazawa T, Miyagi E, Hirahara F, Kitamura H Br J Cancer. 1997; 76(7):829-35.

PMID: 9328139 PMC: 2228076. DOI: 10.1038/bjc.1997.471.

Establishment and characterization of a human colon cancer cell line, OUMS-23, from a patient with familial adenomatous polyposis.

Miyazaki M, Tsuboi S, Mihara K, Kosaka T, FUKAYA K, Kino K J Cancer Res Clin Oncol. 1996; 122(2):95-101.

PMID: 8576285 DOI: 10.1007/BF01226266.

References

Moll R, Lowe A, Laufer J, Franke W . Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992; 140(2):427-47. PMC: 1886432. View

van Niekerk C, Jap P, Ramaekers F, van de Molengraft F, Poels L . Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol. 1991; 165(2):145-52. DOI: 10.1002/path.1711650210. View

Moll R, Pitz S, Levy R, Weikel W, Franke W, Czernobilsky B . Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas. Hum Pathol. 1991; 22(10):989-1001. DOI: 10.1016/0046-8177(91)90007-c. View

Rutzky L, Tomita J, Calenoff M, Kahan B . Human colon adenocarcinoma cells. III. In vitro organoid expression and carcinoembryonic antigen kinetics in hollow fiber culture. J Natl Cancer Inst. 1979; 63(4):893-902. View

Moll R, Franke W, Schiller D, Geiger B, Krepler R . The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982; 31(1):11-24. DOI: 10.1016/0092-8674(82)90400-7. View

Moll R, Krepler R, Franke W . Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation. 1983; 23(3):256-69. DOI: 10.1111/j.1432-0436.1982.tb01291.x. View

Shi Z, Tsao D, Kim Y . Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines. Cancer Res. 1983; 43(9):4045-9. View

Osborn M, van Lessen G, Weber K, Kloppel G, Altmannsberger M . Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest. 1986; 55(4):497-504. View

Lynch M, Oguin W, Hardy C, Mak L, Sun T . Acidic and basic hair/nail ("hard") keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to "soft" keratins. J Cell Biol. 1986; 103(6 Pt 2):2593-606. PMC: 2114622. DOI: 10.1083/jcb.103.6.2593. View

10.

Hill B, Whelan R, Gibby E, Sheer D, Hosking L, Shellard S . Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Int J Cancer. 1987; 39(2):219-25. DOI: 10.1002/ijc.2910390216. View

11.

Miotti S, Canevari S, Menard S, Mezzanzanica D, Porro G, Pupa S . Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer. 1987; 39(3):297-303. DOI: 10.1002/ijc.2910390306. View

12.

Wolf C, Hayward I, Lawrie S, Buckton K, McIntyre M, Adams D . Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer. 1987; 39(6):695-702. DOI: 10.1002/ijc.2910390607. View

13.

Pitz S, Moll R, Storkel S, Thoenes W . Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab Invest. 1987; 56(6):642-53. View

14.

Azumi N, Battifora H . The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol. 1987; 88(3):286-96. DOI: 10.1093/ajcp/88.3.286. View

15.

Franke W, Moll R . Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation. 1987; 36(2):145-63. DOI: 10.1111/j.1432-0436.1987.tb00189.x. View

16.

van Niekerk C, Poels L, Jap P, Smeets D, Thomas C, Ramaekers F . Characterization of a human ovarian carcinoma cell line, OTN 14, derived from a mucinous cystadenocarcinoma. Int J Cancer. 1988; 42(1):104-11. DOI: 10.1002/ijc.2910420120. View

17.

Langdon S, Hawkes M, Hay F, Lawrie S, Schol D, Hilgers J . Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res. 1988; 48(21):6161-5. View

18.

Hills C, Kelland L, Abel G, SIRACKY J, Wilson A, HARRAP K . Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. Br J Cancer. 1989; 59(4):527-34. PMC: 2247140. DOI: 10.1038/bjc.1989.108. View

19.

Giancotti F, Dorsett B, Weaver S, Bharathur R, IOACHIM H, BARBER H . Description of an endometrioid ovarian cancer cell line. Gynecol Oncol. 1989; 35(3):330-7. DOI: 10.1016/0090-8258(89)90073-5. View

20.

Troyanovsky S, Guelstein V, Tchipysheva T, Krutovskikh V, Bannikov G . Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci. 1989; 93 ( Pt 3):419-26. DOI: 10.1242/jcs.93.3.419. View